3O PRODIGE 68 - UCGI 38 - SOREGATT: A randomized phase II study comparing the sequences of regorafenib (reg) and trifluridine/tipiracil (t/t) after failure of standard therapies in patients (pts) with metastatic colorectal cancer (mCRC)
Authors:
- M.P. DucreuxMDM.P. Ducreux
- M. Ben AbdelghaniMAM. Ben Abdelghani
- D. TougeronDTD. Tougeron
- O. BoucheOBO. Bouche
- J. ViaudJVJ. Viaud
- F. Khemissa AkouzFAF. Khemissa Akouz
- J. Martin-BabauJMJ. Martin-Babau
- J-B. BachetJBJ-B. Bachet
- C. CoutzacCCC. Coutzac
- H. CastanieHCH. Castanie
- J. TaiebJTJ. Taieb
- J.M. PhelipJPJ.M. Phelip
- 29 June 2024
- journal article
- abstracts
- Published by Elsevier in Annals of Oncology
- Vol. 35, S3